Allen Salmasi - 14 Aug 2025 Form 4 Insider Report for VEEA INC. (VEEA)

Role
Chief Executive Officer, Director
Signature
/s/ Allen Salmasi
Issuer symbol
VEEA
Transactions as of
14 Aug 2025
Net transactions value
+$10,478,192
Form type
4
Filing time
27 Aug 2025, 19:31:20 UTC
Previous filing
06 Jan 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Salmasi Allen Chief Executive Officer, Director 164 EAST 83RD STREET, NEW YORK /s/ Allen Salmasi 27 Aug 2025 0001367633
NLabs Inc. 10%+ Owner 164 EAST 83RD STREET, NEW YORK NLabs Inc. By: /s/ Janice K, Smith 27 Aug 2025 0002025902

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VEEA Common Stock Other $5,239,096 +5,239,096 +43% $1.00 17,388,017 14 Aug 2025 Direct F1, F2
transaction VEEA Common Stock Other $5,239,096 +5,239,096 +33% $1.00 21,124,580 14 Aug 2025 Owned by NLabs, Inc. F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VEEA Common Warrants Other $0 +5,239,096 $0.000000 5,239,096 14 Aug 2025 Common Stock 5,239,096 $1.10 Direct F3, F4
transaction VEEA Common Warrants Other $0 +5,239,096 $0.000000 5,239,096 14 Aug 2025 Common Stock 5,239,096 $1.10 Owned by NLabs, Inc. F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which shares were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein).
F2 Consists of shares issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 Warrants issued in a public best-efforts offering by the Issuer on the Registration Statement (333-288878) pursuant to Form S-1, which warrants were issued at a public offering price of $1.00 per share and associated common warrant, and which warrant has an exercise price of $1.10 (subject to adjustment as provided therein).
F4 Consists of warrants issued to NLabs Inc., a Delaware corporation, of which is Mr. Salmasi is the CEO and stockholder, pursuant to the above-mentioned offering. Mr. Salmasi disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these warrants in this report shall not be deemed an admission of beneficial ownership of all of the reported warrants for purposes of Section 16 or for any other purpose.